Skip to content
    WR

    Washington Research Foundation

    Washington Research Foundation is a seed to Series B stage investment firm. It has made 30 investments. 30% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $57.8M (across 33 rounds with reported amounts).

    Find people at Washington Research Foundation on Goldilocks AI

    Portfolio

    30

    Fund Size

    —

    Top Stage

    Seed

    Last 12 Mo

    1

    Team

    RH

    Ragan Hart

    Senior Associate for Strategic Investments

    FY

    Frank Yin

    Investment

    JA

    Joe Albe

    Life Science Strategy & Innovation

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    37 investments
    CompanyRoundAmountDate
    BBrainChild BioSeed—Sep 2026
    BBrainChild BioSeries A$116MJan 2026
    Accipiter Biosciences logoAccipiter BiosciencesSeed$12.7MNov 2025
    GROUP14 logoGROUP14Series D$463MAug 2025
    Accipiter logoAccipiterSeed$12.7MJan 2025
    Archon Biosciences logoArchon BiosciencesSeed$20MOct 2024
    Abacus Bioscience logoAbacus BioscienceSeed$4.4MFeb 2023
    SSomalyticsSeed—Aug 2022
    Monod Bio logoMonod BioSeed$25MAug 2022
    SEngine Precision Medicine logoSEngine Precision MedicineSeries A$10MJul 2022
    Arzeda logoArzedaSeries B$33MMar 2022
    KKayoTheraSeries A$8MMar 2022
    Cyrus Biotechnology logoCyrus BiotechnologyUnknown$18MDec 2021
    CCyrusSeed$3.1MJan 2021
    Umoja logoUmojaSeries A$53MNov 2020
    Medcurity logoMedcurityGrowth—Jul 2020
    Medcurity logoMedcuritySeed$200KMay 2020
    Membrion logoMembrionSeries A$6MMar 2020
    Umoja Biopharma logoUmoja BiopharmaSeries A$53MJan 2020
    GROUP14 logoGROUP14Series C$614MAug 2019
    Cyrus Biotechnology logoCyrus BiotechnologySeries A$8MJul 2017
    Wibotic logoWiboticSeed$2.5MSep 2016
    Skytap logoSkytapSeries B$35MDec 2014
    Flexminder logoFlexminderSeries A$1.2MMar 2014
    Juno Therapeutics logoJuno TherapeuticsIpo$264MJan 2014
    Page 1 of 2

    Top Co-Investors

    Last updated: 27 September 2026